Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Communications Medicine|January 30, 2023
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIVJacopo Polvere, Massimiliano Fabbiani, Gabiria Pastore, et al.Journal of Global Antimicrobial Resistance|January 29, 2022
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort studyRoberta Gagliardini, Michela Baccini, Sara Modica, et al.Human Vaccines & Immunotherapeutics|January 28, 2026
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndromeLudovica Soldateschi, Silvia Leoncini, Fabio Fiorino, et al.Infection|October 6, 2018
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent hostSara Modica, Clelia Miracco, Maria Grazia Cusi, et al.Journal of Viral Hepatitis|February 18, 2021
The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation CohortAlessandra Bandera, Patrizia Lorenzini, Lucia Taramasso, et al.Journal of Clinical Medicine|August 14, 2025
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative ReviewCarola Pergolizzi, Chiara Lazzeri, Daniele Marianello, et al.Infectious Diseases and Therapy|November 29, 2024
Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro TrialBarbara Rossetti, Micol Ferrara, Lucia Taramasso, et al.Viruses|May 27, 2023
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected PatientsMassimiliano Fabbiani, Melissa Masini, Barbara Rossetti, et al.Plos One|September 27, 2013
Protective activity of the CnaBE3 domain conserved among Staphylococcus aureus Sdr proteinsMarco Becherelli, Prachi Prachi, Elisa Viciani, et al.Journal of Medical Virology|May 30, 2020
Serum KL-6 concentrations as a novel biomarker of severe COVID-19Miriana d'Alessandro, Paolo Cameli, Rosa Metella Refini, et al.Pageof 8